ARCHIVES

As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel.

This article is from The Cancer Letter archive.

Vol. 26 No. 38 | October 20, 2000

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Awards $1.2 Million To Mt. Sinai To Establish Specialized Cancer Center

July 26, 1974

Possible Breach of Patient Confidentially By Calif. Physician; NCI

May 6, 1994

New Version Of NCI Proposed IP Agreement Quiets Some Unease At Cooperative Groups; Advisors Urge “No Paralysis” While Awaiting New Language

November 13, 2009

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001

Reagan Family History Shows String Risk Factor

August 2, 1985

House: NCI Should Coordinate National Cancer Program

August 4, 1995